easy

1. BIONIC PANCREAS

3. Introduction
History
Bi-Harmonal Automatic Device
Technique
Advantages
Limitations

6. Dr. Edward Damiano & Dr Steven Russels
of Boston University / Massachusetts
General Hospital.
In Year 2005 : 1st Started testing it in pigs.
It is still not FDA approved.
 Most likely 2017 Approval

8. Bionic pancreas will bring the ilet to
market in the name of
“ MEDTRONiCS Mini Med 640G “
Expected to launch in April 2017 after
FDA approval

11. 1. Control
2. Continuous Glucose monitor
3. Insulin and glucagon infusion pump

14. “It is a platform that makes a GREAT drug
BETTER “shared by Dr.Diamino
Past studies of automated insulin delivery
have repeatedly shown that insulin needs
vary dramatically from day to day and
night to night

15. People with type 1 may require
 10 units of insulin on Monday night
 7 units on Tuesday
 13 units on wensday
•Systems like Bionic Pancreas can adapt to
those variations in insulin needs
automatically every 5 mins in personalized
insulin delivery

16. The bionic pancreas has some other exciting
advantages
• Only BODY WEiGHT information is needed to begin
Dosing insulin and Glucagon
• The System quickly adapts with in a day to whatever
specific person needs.

17. Low batteries
Delayed action of subcutaneous infused
insulin
Incorrect adaptations of controlled algorithms
Sensor unavailability due to loss of
communications or non compliance of the pt.

18. Infusion pump
•infusion set occlusion
•Insulin set leakage or dislocation.
•Hardware/ software failures
•Bi harmonal system
•Switching of insulin and glucagon.